Poison Pill

Also in the news for May 28, 2014 . . .

MRSA drug gains approval through govt's rapid process ... Kindred blasts Gentiva over 'poison pill' ... Improved vision increases seniors' fall risk? ... Observation stays for falls increase in WA

Omnicare extends purchase offer for PharMerica until January

Omnicare announced Monday that it is extending its offer to purchase all outstanding shares of rival PharMerica for $15 per share to Jan. 20. The original offer was scheduled to expire Dec. 2.